Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round

TEL AVIV, Israel, June 4, 2020 -- (Healthcare Sales & Marketing Network) -- Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased to announce the closing of a Series B equity financing of $26 million. Inves... Devices, Oncology, Venture Capital Alpha Tau Medical, alpha-radiation, Alpha DaRT, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news